ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer

Published:2018-04 Issue:1 Volume:127 Page:1-5
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Nestle Ursula,De Ruysscher Dirk,Ricardi Umberto,Geets Xavier,Belderbos Jose,Pöttgen Christoph,Dziadiuszko Rafal,Peeters Stephanie,Lievens Yolande,Hurkmans Coen,Slotman Ben,Ramella Sara,Faivre-Finn Corinne,McDonald Fiona,Manapov Farkhad,Putora Paul Martin,LePéchoux Cécile,Van Houtte Paul

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference37 articles.

1. Radio(chemo)therapy in locally advanced nonsmall cell lung cancer;Glatzer;Eur Respir Rev,2016

2. The impact of cancer incidence and stage on optimal utilization of radiotherapy: methodology of a population based analysis by the ESTRO-HERO project;Borras;Radiother Oncol,2015

3. How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis;Borras;Radiother Oncol,2016

4. Expanding global access to radiotherapy;Atun;Lancet Oncol,2015

5. PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014;Konert;Radiother Oncol,2015

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of mediastinal tumor burden and lymphatic spread in locally advanced non-small-cell lung cancer: A secondary analysis of the multicenter randomized PET-Plan trial;Radiotherapy and Oncology;2024-11

2. Parallel explorations in LA-NSCLC: Chemoradiation dose-response optimisation considering immunotherapy and cardiac toxicity sparing;Radiotherapy and Oncology;2024-11

3. “Mid-P strategy” versus “internal target volume strategy in locally advanced non small cell lung cancer: Clinical results from the randomized non-comparative phase II study Mid-P;Radiotherapy and Oncology;2024-10

4. Dosimetric comparison of nodal clinical target volume for locally advanced non‑small cell lung cancer: Options for geometric expansion vs. lymph node stations;Molecular and Clinical Oncology;2024-06-26

5. Systematic endoscopic staging of mediastinum to guide radiotherapy planning in patients with locally advanced non-small-cell lung cancer (SEISMIC): an international, multicentre, single-arm, clinical trial;The Lancet Respiratory Medicine;2024-06